We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Radiofrequency Ablation Can Destroy Lung Tumors

By HospiMedica staff writers
Posted on 10 Aug 2004
Radiofrequency ablation (RFA), the utilization of electrodes to heat and eradicate abnormal tissue, is a promising method to safely and successfully treat patients with inoperable lung tumors, according to a recent Italian study.

In a study of 18 patients with lung tumors not eligible for surgery, 40 nodules were treated by lung RFA. More...
On regular follow-up, no relapse was detected in 94% of the patients. The study was published in the August 2004 issue of the American Journal of Roentgenology.

According to Cosmo Gadaleta, M.D., from the IRCCS Hospital of Oncology (Bari, Italy), a lead author of the study, most lung tumors are inoperable because of coexisting health problems or poor respiratory function in the patient. A number of these kinds of inoperable tumors have been treated using radiotherapy, which can cause serious toxicity in a patient, and chemotherapy, which is not tolerable by all patients.

"Lung RFA can get around all those problems. It is minimally invasive, with only a small needle being inserted into the patient. It is also advantageous because of potentially low costs, short hospitalization times, and good patient tolerance without mortality, stated Dr. Gadaleta.

Complications caused by lung RFA were minor and included pneumothorax. Pneumothorax occurred in a small percentage of cases, and each occurrence was treated successfully with pleural drainage, according to Dr. Gadaleta. "The risk is small when compared to the benefits of lung RFA, and since the radiology team anticipates the possibility of pneumothorax developing as a result of the procedure, they carefully monitor the patient so they can quickly treat any complications.”

Dr. Gadaleta also stated that lung RFA is a promising technique for treating patients with certain operable lung tumors. "We feel that lung RFA could become more prevalent, first for patients who are not candidates for surgery, but also as an alternative to surgery for operable primary lung tumors, as long as the tumor is not too large.”


Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gynecological Examination Chair
arco-matic
Infrared Digital Thermometer
R1B1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.